Vaxart to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 8
October 20 2022 - 8:30AM
Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a
business update and report financial results for the third quarter
ended September 30, 2022 after the market close on Tuesday,
November 8, 2022. The Vaxart senior management team will host a
conference call on the same day, beginning at 4:30 p.m. ET.
The conference call can be accessed using the
following information:
Webcast: Click hereDate: Tuesday, November 8,
2022 – 4:30 p.m. ETDomestic: 888-437-3179International:
862-298-0702Conference ID: 13733692
A replay of the webcast will be available on the
Company’s website at www.vaxart.com following the conclusion of the
event.
About VaxartVaxart is a
clinical-stage biotechnology company developing a range of oral
recombinant vaccines based on its proprietary delivery platform.
Vaxart vaccines are designed to be administered using tablets that
can be stored and shipped without refrigeration and eliminate the
risk of needle-stick injury. Vaxart believes that its proprietary
tablet vaccine delivery platform is suitable to deliver recombinant
vaccines, positioning the company to develop oral versions of
currently marketed vaccines and to design recombinant vaccines for
new indications. Vaxart’s development programs currently include
tablet vaccines designed to protect against coronavirus, norovirus,
seasonal influenza, and respiratory syncytial virus (RSV), as well
as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s
first immune-oncology indication. Vaxart has filed broad domestic
and international patent applications covering its proprietary
technology and creations for oral vaccination using adenovirus and
TLR3 agonists.
Contacts
Vaxart Media Relations: |
Investor Relations: |
Mark Herr |
Andrew Blazier |
Vaxart, Inc. |
FINN Partners |
mherr@vaxart.com |
IR@Vaxart.com |
(203) 517-8957 |
(646) 871-8486 |
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Apr 2023 to Apr 2024